Abiraterone and increased survival in metastatic prostate cancer

N Engl J Med. 2011 Aug 25;365(8):767. doi: 10.1056/NEJMc1107198.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Bone Neoplasms / drug therapy
  • Bone Neoplasms / secondary*
  • Humans
  • Male
  • Neoplasm Metastasis
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / pathology
  • Radium / therapeutic use*

Substances

  • Antineoplastic Agents
  • Radium